doxorubicin hydrochloride has been researched along with marchantin c in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, HH; Kong, F; Lou, HX; Sun, B; Xi, GM; Yuan, HQ | 1 |
Hu, QW; Li, L; Lou, HX; Niu, HM; Sun, B; Xie, F; Yuan, HQ; Zheng, HB | 1 |
Hu, QW; Li, L; Lou, HX; Niu, HM; Sun, B; Tang, H; Yuan, HQ; Zheng, HB | 1 |
3 other study(ies) available for doxorubicin hydrochloride and marchantin c
Article | Year |
---|---|
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bibenzyls; Catechols; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Ethers, Cyclic; Humans; Phenyl Ethers; Rhodamine 123; Stilbenes; Vincristine | 2010 |
Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Humans; Macrocyclic Compounds; Molecular Docking Simulation; Protein Multimerization; Protein Structure, Quaternary; Structure-Activity Relationship; Tubulin Modulators | 2016 |
Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
Topics: Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Macrocyclic Compounds; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2017 |